Surgical approaches in 84 patients with insulinomas in multiple endocrine neoplasia type 1 (MEN 1) Abstract #58

Introduction: Management of insulinomas in the setting of Multiple Endocrine Neoplasia type 1 (MEN1) remains controversial.
Aim(s): To evaluate long-term results of various surgical approaches in the control of hypoglycemia in insulinoma-MEN 1 patients and to characterize other parameters involved in the therapeutic decision–making process (WHO status at diagnosis, post-operative morbidity, functioning and non-functioning duodenopancreatic recurrences).
Materials and methods: All 84 consecutive patients with insulinoma and MEN1 from 30 French centers of the GTE were retrospectively studied. They had clinical and biochemical diagnosis of insulinoma and MEN 1 syndrome according to the standardized definitions. Results are classified as a function of surgery: total pancreatectomy (TP), cephalic duodenopancreatectomy (CDP), splenopancreatectomy (SPC), or enucleation alone (E). Definitive cure of insulinoma was defined as absence of recurrence of symptomatic hypoglycaemia during the follow-up. Recurrences were classified in three subgroups: functioning syndrome (hypoglycemia or non-hypoglycaemia) and pancreatic tumor. Permanent postoperative adverse effects were recorded.

To read results and conclusion, please login ...

Further abstracts you may be interested in

#83 Surgical treatment of duodenopancreatic neuroendocrine tumors (pNETs) in patients with multiple endocrine neoplasia type 1 (MEN 1): a Dutch consensus statement
Introduction: Duodenopancreatic neuroendocrine tumors (pNETs) in multiple endocrine neoplasia type 1 (MEN 1) are the most important cause of MEN 1-related death. Surgery is the only curative treatment, but controversy exists on the optimal strategy. Recent guidelines on pNETs have limited recommendations specific for MEN 1. Therefore, a Dutch multidisciplinary consensus meeting was organized.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: MD Carolina RC Pieterman
#348 Management of Multiple Endocrine Neoplasia Type 1 in Patients with Pancreatic Neuroendocrine Tumors
Introduction: Screening for MEN-1 is an integral part of examination of patients with pNETs because revelation of this hereditary pathology radically influences tactics of treatment.
Conference:
Category: Basic
Presenting Author: Ivan Vasiliev
#2732 Prostate Metastasis of Medullary Thyroid Carcinoma in a Young Patient with MEN2B Syndrome
Introduction: Multiple Endocrine Neoplasia 2B is associated with particularly early onset medullary thyroid carcinoma (MTC). Metastatic MTC is the leading cause of early death in MEN2B. The usual sites of metastasis are neck, mediastinum, lung, liver, bone and brain.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Case reports
Presenting Author: Dr Jane Noble
Authors: Noble J, Forde H, Crowley R, ...
#2737 Identification of a Novel MAFA Missense Mutation Causing Familial Insulinomatosis
Introduction: Insulinomatosis is a rare pancreatic disease characterized by an adult-onset condition of recurrent hyperinsulinemic hypoglycemia caused by multiple insulin-secreting neuroendocrine tumors.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: PD. Dr. Christian Fottner
#2764 Cystic Pancreatic Neuroendocrine Tumors. Can We Diagnose Them Preoperatively?
Introduction: Pancreatic neueroendocrine tumors rarely undergo cystic changes but they are often misdiagnosed as pancreatic mucinous cystadenoma, mucinous cystadenocarcinoma, serous cystadenoma, and solid and cystic papillary tumors, or pseudocyst.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Imaging and Interventions (radiology, endoscopy)
Presenting Author: Dr Arooj Fatima
Authors: Fatima A, Zaidi S S A, ...